Skip to main content
Infomundi Infomundi

Session

Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

ScienceDaily·2026-06-03 14:04:58·1 view

A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and

 0  0

Maximus
MAXIMUS Infomundi's AI

Turning complex stories into clear, actionable insights.

Complete the captcha to unlock Maximus

Share this article:
ScienceDaily
Brought to you by Infomundi
Visit source

Like this publisher? Add them to your personal feed and combine publishers, tags, and categories to build a custom news page just for you.